AI-based differential diagnosis of dementia etiologies on multimodal data
AI-based differential diagnosis of dementia etiologies on multimodal data
Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods
Multimodal deep learning for Alzheimer’s disease dementia assessment
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Does clinically measured walking capacity contribute to real-world walking performance in Parkinson's disease?
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study
Profile of social self-management practices in daily life with Parkinson’s disease is associated with symptom severity and health quality of life
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Cognitive-Behavioral Therapy for Anxiety in Parkinson’s Disease
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Comparative Effectiveness of mHealth-Supported Exercise Compared With Exercise Alone for People With Parkinson Disease: Randomized Controlled Pilot Study
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
Mapping spontaneous facial expression in people with Parkinson’s disease: A multiple case study design
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
Stigma as a key determinant of health-related quality of life in Parkinson’s disease
A randomized trial of inhaled levodopa (CVT‐301) for motor fluctuations in Parkinson's disease
The Relationship between the Experience of Hypomimia and Social Wellbeing in People with Parkinson’s Disease and their Care Partners
Racial Disparities in Parkinson Disease: A Systematic Review of the Literature
Highly Challenging Balance Program Reduces Fall Rate in Parkinson Disease
Head injury at early ages is associated with risk of Parkinson's disease
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)
Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
Emergence and evolution of social self-management of Parkinson’s disease: study protocol for a 3-year prospective cohort study
Feasibility of a Virtual Exercise Coach to Promote Walking in Community-Dwelling Persons with Parkinson Disease
Safinamide as an Add-On Therapy to a Stable Dose of a Single Dopamine Agonist: Results from a Randomized, Placebo-Controlled, 24-Week Multicenter Trial in Early Idiopathic Parkinson Disease (PD) Patients (MOTION Study) (P01.061)